The deal involves a major change in how the UK values drugs and will apply to all new medicines, not just US ones.
The spending increase will stay in place for at least the next three years.
By Reuters
Share
Save
Save articles to read later and create your own reading list.
The U.S. announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology which will lead to…
Agreement also calls for NHS to increase net price it pays for new medicines by 25%
The expected deal follows threats of tariffs as high as 100% on branded drug imports.
The United States and the United Kingdom have agreed on a zero-tariffs deal for medications manufactured in Britain. The NHS will…
‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments
Government prepares to boost spending on medicines to avoid a tariff hit
U.S. announces zero tariff pharmaceutical deal with Britain
UK and US agree zero-tariff pharmaceuticals deal
US and UK set to agree zero tariffs deal on pharmaceuticals
U.K. and U.S. reach deal for zero tariffs on British-made pharmaceuticals - UPI.com
NHS to increase medicines spending to avoid threatened Trump tariffs
